Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia

Study Identifier
MedAff-BTX-0716
CT.gov Identifier
NCT01384214
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Neuroscience - Other
    • Study Drug
  • botulinum toxin Type A
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18 - 75 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosed with cervical dystonia * Successfully completed Allergan study MedAff BTX-0616 with 16 weeks since last botulinum toxin Type A injection * In need of additional botulinum toxin Type A injections
    Exclusion Criteria:
    * Surgery or spinal cord stimulation for cervical dystonia * Previous injections of phenol or alcohol for cervical dystonia

    Protocol Summary

    The purpose of this study is to evaluate swallowing efficiency in patients with cervical dystonia following treatment with botulinum toxin Type A.

    Study Locations

    Location
    Status
    Location
    Zagreb, Croatia
    Status
    Not applicable